Invention Grant
US09334320B2 Methods of treating moderate to severe hidradenitis suppurativa with anti-TNFalpha antibody
有权
用抗TNFα抗体治疗中重度肥胖性荨麻疹的方法
- Patent Title: Methods of treating moderate to severe hidradenitis suppurativa with anti-TNFalpha antibody
- Patent Title (中): 用抗TNFα抗体治疗中重度肥胖性荨麻疹的方法
-
Application No.: US14289115Application Date: 2014-05-28
-
Publication No.: US09334320B2Publication Date: 2016-05-10
- Inventor: Martin M. Okun , Thomas C. Harris
- Applicant: AbbVie Biotechnology, Ltd.
- Applicant Address: BM Hamilton
- Assignee: AbbVie Biotechnology Ltd.
- Current Assignee: AbbVie Biotechnology Ltd.
- Current Assignee Address: BM Hamilton
- Agency: Foley Hoag LLP
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/24 ; A61K39/00
Abstract:
The invention provides methods, uses and compositions for the treatment of hidradenitis suppurativa. The invention describes methods and uses for treating hidradenitis suppurativa, wherein a TNFα inhibitor, such as a human TNFα antibody, or antigen-binding portion thereof, is used to treat hidradenitis suppurativa in a subject. Also described are methods for determining the efficacy of a TNFα inhibitor for treating hidradenitis suppurativa in a subject.
Public/Granted literature
- US20150147335A1 Use of TNFalpha Antibody for Treatment of Hidradenitis Suppurativa (HS) Public/Granted day:2015-05-28
Information query
